Integrative multi-omics and drug-response characterization of patient-derived prostate cancer primary cells.
Wang Z, Li Y, Zhao W, Jiang S, Huang Y, Hou J, Zhang X, Zhai Z, Yang C, Wang J, Zhu J, Pan J, Jiang W, Li Z, Ye M, Tan M, Jiang H, Dang Y.
Wang Z, et al. Among authors: hou j.
Signal Transduct Target Ther. 2023 May 1;8(1):175. doi: 10.1038/s41392-023-01393-9.
Signal Transduct Target Ther. 2023.
PMID: 37121942
Free PMC article.